Document is current
Any future updates will be listed below
-
Authors
Cao, Mei https://orcid.org/0009-0007-8209-4854
Yuan, Guo-Hua https://orcid.org/0000-0002-8459-3784
Cao, Shi-Meng https://orcid.org/0009-0000-8150-9359
Liu, Yu-Xin
Liu, Chu-Xiao https://orcid.org/0000-0002-6725-8327
Xu, Yi-Feng https://orcid.org/0000-0002-5111-8565
Wei, Jia
Guo, Yi-Lin
Chen, Ling-Ling https://orcid.org/0000-0001-9501-0305
-
Funding
Funding for this research was provided by:
National Key R&D Program of China
- License Information
-
More Information
Article History
Received: 17 October 2024
Accepted: 26 August 2025
First Online: 29 September 2025
Competing interests
: L.-L.C. is a scientific co-founder of RiboX Therapeutics. L.Y. and M.C. have filed a patent application (2024119726080) relating to this work through Children’s Hospital of Fudan University. The remaining authors declare no competing interests.
